Cochrane

Dr. Cochrane, please.

Also Dr. Cochrane... and Yours Truly.

But Archie Cochrane was a resourceful person.

Now I'm not telling you this story because I think Archie Cochrane is a dude, although Archie Cochrane is a dude.

But Cochrane would do that kind of thing.

And Archie Cochrane understood this as well as anybody.

Dr. Cochrane told him he might never have any.

Kyle, I went to see Dr. Cochrane this morning.

Dr. Cochrane, wouldyou tell this inquest about the threat, please?

Cochrane understood that uncertainty, that fallibility, that being challenged, they hurt.

So Cochrane then goes to the Germans who are running the prison camp.

Archie Cochrane, is a prisoner of war and a doctor, and he has a problem.

But it s theoretical nihilism, Cochrane argues, to ascribe these excessive fluctuations to irrationality as Krugman does.

And this man, Archie Cochrane, is a prisoner of war and a doctor, and he has a problem.

Nellie Bly (May 5, 1864 January 27, 1922) was the pen name of American journalist Elizabeth Jane Cochrane.

Rather than defend that theory, Cochrane admits that asset prices move more than reasonable expectations of future cash flows.

And Archie Cochrane, as the camp doctor, was one of the first men in to clear up the mess.

The Nordic Cochrane Group were trying to get a hold of the data on that to bring it all together.

Krugman is hampered by the fact that he attributes the crash to irrationality, which, as Cochrane points out, is no theory.

The Cochrane Groups are an international nonprofit collaboration that produce systematic reviews of all of the data that has ever been shown.

The latest slugfest features New Keynesian champion Paul Krugman of Princeton University and New Classical champion John Cochrane of the University of Chicago.

Cochrane accuses Krugman of misleading his readers about the efficient market theory, which asserts that, given the available information, financial markets always get asset prices right.

When he gets around to economics, Cochrane aims his blows at two points Krugman s attack on the efficient market theory and his advocacy of fiscal stimulus for depressed economies.

I'm telling you this story because Archie Cochrane, all his life, fought against a terrible affliction, and he realized it was debilitating to individuals and it was corrosive to societies.

I'm telling you this story because Archie Cochrane, all his life, fought against a terrible affliction, and he realized it was debilitating to individuals and it was corrosive to societies.

The Cochrane Collaboration, an international non profit organization providing healthcare information, conducted a systematic review of the benefits of acupuncture, including 14 trials, of which 10 were conducted in China, involving 1,208 patients.

On the question of what caused the crash, the debate is more even. Krugman is hampered by the fact that he attributes the crash to irrationality, which, as Cochrane points out, is no theory.

Krugman s heavy pounding of Chicago School economics goaded Cochrane, a professor of finance, into some bad tempered counter punching on the university s Web site, much of which consisted of a personal attack on Krugman s scientific integrity.

Cochrane, he starts ranting at these Germans in this Scottish accent in fluent German, by the way, but in a Scottish accent and explains to them how German culture was the culture that gave Schiller and Goethe to the world.

Cochrane, he starts ranting at these Germans in this Scottish accent in fluent German, by the way, but in a Scottish accent and explains to them how German culture was the culture that gave Schiller and Goethe to the world.

Now when the Cochrane systematic reviewers were trying to collect together all of the data from all of the trials that had ever been conducted on whether Tamiflu actually did this or not, they found that several of those trials were unpublished.

The infectious diseases Cochrane Group, which are based in Italy, has been trying to get the full data in a usable form out of the drug companies so that they can make a full decision about whether this drug is effective or not, and they've not been able to get that information.

The infectious diseases Cochrane Group, which are based in Italy, has been trying to get the full data in a usable form out of the drug companies so that they can make a full decision about whether this drug is effective or not, and they've not been able to get that information.